Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Dividends Paid - Common (2017 - 2025)

Historic Dividends Paid - Common for Fortress Biotech (FBIO) over the last 9 years, with Q3 2025 value amounting to $166000.0.

  • Fortress Biotech's Dividends Paid - Common changed N/A to $166000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $498000.0, marking a year-over-year decrease of 9173.31%. This contributed to the annual value of $4.0 million for FY2024, which is 5000.0% down from last year.
  • As of Q3 2025, Fortress Biotech's Dividends Paid - Common stood at $166000.0.
  • Over the past 5 years, Fortress Biotech's Dividends Paid - Common peaked at $2.0 million during Q4 2021, and registered a low of $166000.0 during Q1 2025.
  • Moreover, its 5-year median value for Dividends Paid - Common was $188000.0 (2021), whereas its average is $1.0 million.
  • Per our database at Business Quant, Fortress Biotech's Dividends Paid - Common surged by 98540.54% in 2024 and then tumbled by 9173.31% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Dividends Paid - Common stood at $2.0 million in 2021, then dropped by 0.05% to $2.0 million in 2022, then increased by 0.05% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then plummeted by 91.73% to $166000.0 in 2025.
  • Its Dividends Paid - Common stands at $166000.0 for Q3 2025, versus $166000.0 for Q2 2025 and $166000.0 for Q1 2025.